Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Concert Pharmaceuticals"
Count: 30
Selected: 0
NCT IDTitle
NCT05041803European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT04797650A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)
NCT04784533A Phase 2 Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04518995A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)
NCT03898479Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT05192369A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers
NCT04158687A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia
NCT01487109A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
NCT04843540Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects
NCT04743414Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects
NCT03941548Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03811912Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
NCT04309643Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
NCT03137381Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04092712Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
NCT03880253Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers
NCT03880136Food Effect Study of CTP-543 in Healthy Volunteers
NCT03830463Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers
NCT03778320A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers
NCT02960945Open-Label Crossover Study Comparing CTP-543 to Jakafi®
NCT02777008Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects
NCT02680249Food Effect Study of CTP-656 in Healthy Male Volunteers
NCT02599792Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656
NCT02404922Multiple Ascending Dose Study in Healthy Volunteers
NCT02392702Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects
NCT02239081A Safety and Tolerability Study of CTP-730 in Healthy Volunteers
NCT02215499A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
NCT01460199Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
NCT01458769Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz
NCT01328821Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499